WGU C980 Assignment 1 | 2026 Latest Update with
Complete Solution
Instructions:
Use this worksheet to categorize the characteristics of the Hackensack Alliance ACO innovation as being
disruptive, sustaining, and both disruptive and sustaining. Use the resources, including the Hackensack
case study, in this assignment to complete the chart.
Please include examples in each of the columns below.
Disruptive Innovation Disruptive and Sustaining Innovation Sustaining Innovation
mHealth Technology would be considered a disruptive innovation. This technology creates a new market
and value network in terms of utilizing mobile technology for access to healthcare (Hackensack ACO,
2014).
Establishing a mobile disease
surveillance and management tool for the patients
utilization in their homes would also be regarded as a disruptive innovation secondary to mHealth
Technology.
• Health Recovery Solutions and its PatientConnect 4G tablet platform.
The Hackensack ACO can also be considered a disruptive innovation because it changed the method in
terms of the way nursing staff
managed the daily aspects of patient care such as patient education, patient interaction, and tracking
patient self-management
of their heart failure (Hackensack ACO, 2014). The Health Recovery Solutions and its PatientConnect
4G tablet platform can be considered sustaining innovation and disruptive because of the new method
of integration which alters the competition landscape. However, the 4G tablet platform is also a
sustaining innovation because it lowers manufacturing cost (Hackensack ACO, 2014). The Health
Recovery Solutions and its PatientConnect 4G tablet platform can be considered a sustaining innovation
because it has the potential to reduce production and supply costs in order to enhance profit margins
and the market share (Hackensack ACO, 2014).
Furthermore, the Hackensack ACO is a sustainable innovation because the implementation of tablet
platform improves existing product features in terms of mHealth and Telehealth delivery methods
thereby decreasing delivery cost (Hackensack ACO, 2014).
Additionally, this new method reduces
readmissions rate and provides quality of care through the ability to improve surveillance and
Complete Solution
Instructions:
Use this worksheet to categorize the characteristics of the Hackensack Alliance ACO innovation as being
disruptive, sustaining, and both disruptive and sustaining. Use the resources, including the Hackensack
case study, in this assignment to complete the chart.
Please include examples in each of the columns below.
Disruptive Innovation Disruptive and Sustaining Innovation Sustaining Innovation
mHealth Technology would be considered a disruptive innovation. This technology creates a new market
and value network in terms of utilizing mobile technology for access to healthcare (Hackensack ACO,
2014).
Establishing a mobile disease
surveillance and management tool for the patients
utilization in their homes would also be regarded as a disruptive innovation secondary to mHealth
Technology.
• Health Recovery Solutions and its PatientConnect 4G tablet platform.
The Hackensack ACO can also be considered a disruptive innovation because it changed the method in
terms of the way nursing staff
managed the daily aspects of patient care such as patient education, patient interaction, and tracking
patient self-management
of their heart failure (Hackensack ACO, 2014). The Health Recovery Solutions and its PatientConnect
4G tablet platform can be considered sustaining innovation and disruptive because of the new method
of integration which alters the competition landscape. However, the 4G tablet platform is also a
sustaining innovation because it lowers manufacturing cost (Hackensack ACO, 2014). The Health
Recovery Solutions and its PatientConnect 4G tablet platform can be considered a sustaining innovation
because it has the potential to reduce production and supply costs in order to enhance profit margins
and the market share (Hackensack ACO, 2014).
Furthermore, the Hackensack ACO is a sustainable innovation because the implementation of tablet
platform improves existing product features in terms of mHealth and Telehealth delivery methods
thereby decreasing delivery cost (Hackensack ACO, 2014).
Additionally, this new method reduces
readmissions rate and provides quality of care through the ability to improve surveillance and
